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LETTER TO THE EDITOR
Systemic hypertension and the
pathogenesis of diffuse alveolarF
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To  the  Editor,
Diffuse  alveolar  haemorrhage  (DAH)  is  a  rare,  life-
threatening  syndrome,  characterized  by  progressive  alveo-
lar  inﬁltrates,  anaemia  and  haemoptysis.  DAH  is  a  medical
emergency,  requiring  prompt  identiﬁcation  and  treatment,
but  this  may  be  hindered  by  an  absence  of  haemopty-
sis  or  non-acute  presentation.  A  comprehensive  search  for
the  underlying  cause  is  imperative,  as  this  will  guide  any
effective  treatment.  It  is  important  to  note  that  different
aetiologies  are  associated  with  speciﬁc  pathogenesis.  We
describe  the  case  of  a  patient  with  malignant  hypertension
(MH)  presenting  with  DAH,  we  review  previous  reports  on
this  association  and  discuss  the  implications  on  the  patho-
genesis  and  clinical  management  of  DAH.
A  51-year-old  male  presented  with  a  dry  cough  and  mild
dyspnoea  which  had  lasted  four  days.  He  was  a  ﬁnancial
consultant,  a  heavy  smoker  and  had  a  history  of  chronic
sinusitis  but  without  any  prescribed  medication.  The  phys-
ical  examination  revealed  no  signs  of  respiratory  distress,
a  bilateral  blood  pressure  (BP)  of  220//130  mmHg,  and
left  basal  crackles.  An  echocardiography  revealed  signs
of  mild  aortic,  mitral  and  tricuspid  regurgitation  and  a
chest  X-ray  showed  bilateral  perihilar  ‘‘butterﬂy  pattern’’
alveolar  inﬁltrates.  Blood  tests  showed  severe  renal  fail-
ure,  hypokalaemia  and  normocytic  anaemia  (creatinine:
8.02  mg/dL  (reference  values  (RV):  0.72--1.18),  potassium:
2.0  mmol/L  (RV:  3.5--5.1),  haemoglobin:  11.2  g/dL  (RV:
13.0--17.0)).  Laboratory  coagulation  tests  were  normal  (pro-
thrombin  time:  16.2  s  (RV:  12.0--17.4),  prothrombin  77%  (RV:
70--120)).  An  arterial  blood  gas  analysis  showed  respira-
tory  alkalosis  with  a  PaO2  level  of  63  mmHg  (RV  83--108).  A
non-contrast  chest  CT  found  bilateral  central  parenchymal
inﬁltrates  with  a  ‘‘crazy  paving’’  pattern  (Fig.  1)  and  a  renal
ultrasound  found  bilateral  increased  kidney  echogenicity
with  preserved  size.  A  bronchoscopy  with  bronchoalveo-
lar  lavage  was  performed,  and  progressively  bloody  ﬂuid
was  retrieved.  Urinalysis  showed  microscopic  haematuriaPlease  cite  this  article  in  press  as:  Duarte  JC,  et  al.  System
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and  proteinuria  (+++)  with  a  spot  urine  sample  protein  to
creatinine  ratio  of  2380  mg/g  (RV:  <200).  Fundoscopic  exam-
ination  identiﬁed  signs  of  hypertensive  optic  neuropathy,
and  the  patient  was  admitted  for  malignant  hypertension,
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arenchymal  inﬁltrates  with  a  ‘‘crazy  paving’’  pattern.
nder  aggressive  anti-hypertensive  therapy.  He  remained
table  and  the  pulmonary  inﬁltrates  improved,  but  poor
enal  function  and  difﬁcult  hypertension  continued.  Fur-
her  study  revealed  cytoplasmic  iron  deposits  in  alveolar
acrophages  with  a  moderate  alveolar  haemorrhage  but
o  signs  of  pulmonary  infection.  The  auto-immune  panel
as  negative,  including  anti-nuclear  antibodies,  proteinase-
-antineutrophil  cytoplasmic  antibodies,  myeloperoxidase-
ntineutrophil  cytoplasmic  antibodies,  anti-glomerular
asement  membrane  antibodies,  cryoglobulins  and  rheuma-
oid  factors.  Complement  levels  were  normal  and  viral
erologies  were  negative.  The  plasma  renin  was  1090  U/ml
RV:  7--76),  aldosterone  was  5660  pg/ml  (RV:  30--310),  and
ldosterone  to  renin  activity  ratio  was  6.3  ng/ng  (RV:  14.5).
n  abdominal  CT  scan  revealed  a  left  adrenal  nodule  and
 renal  eco  Doppler  excluded  renal  artery  stenosis.  An
ltrasound  guided  kidney  biopsy  was  performed  revealing
ypertensive  nephroangiosclerosis  with  chronic  interstitial
ephritis  and  arterio-sclerosis  and  arteriolo-sclerosis.  There
as  no  evidence  of  active  necrotizing  glomerulonephri-
is,  crescent  formation,  immune  deposits  or  vasculitis.  The
rocedure  was  complicated  by  late  bleeding  and  renal
aematoma  requiring  embolization  of  the  left  renal  artery.ic  hypertension  and  the  pathogenesis  of  diffuse  alveolar
016/j.rppnen.2016.10.002
fter  the  embolization,  normalization  of  blood  pressure  and
otassium  levels  were  noted.  A  new  evaluation  of  plasma
enin  and  aldosterone  levels  showed  normal  results.  The
Elsevier Espan˜a, S.L.U. This is an open access article under the CC
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Table  1  Clinical  characteristics  of  all  reports  of  malignant  hypertension  with  diffuse  alveolar  haemorrhage.
Case  Age  Gender  Nationality  Smoking  Previous  HT  Family  history  of  HT  Air  travel  Ref.
1  34  Male  Japanese  NR  1  month  NR  NR  1
2  26  Male  North  American  1--2  cig./day  No  Both  parents  Yes  5
3  26  Male  Japanese  NR  3  years  NR  Yes  3
4  38  Male  Canadian  9  packs-year 3  months  NR  NR  4
5  32  Male  Japanese  NR  5  years  Both  parents  NR  6
6  27  Male  Japanese  >30  pack-year  No  NR  NR  2
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HT: systemic hypertension; cig.: cigarette; NR: no reference; Ref.
atient  became  asymptomatic;  there  was  complete  res-
lution  of  pulmonary  inﬁltrates  and  hypoxaemia,  but  no
ecovery  of  renal  function,  requiring  chronic  haemodialysis.
he  ﬁnal  diagnosis  was  probable  adrenal  reninoma,  lead-
ng  to  malignant  hypertension,  diffuse  alveolar  haemorrhage
nd  chronic  renal  failure.
We  report  a  patient  with  a  probable  reninoma  leading  to
evere  systemic  hypertension  and  subsequent  diffuse  alve-
lar  haemorrhage.  Although  we  could  not  get  histological
onﬁrmation  of  the  reninoma,  the  left  adrenal  node,  strikin-
ly  elevated  levels  of  renin  and  prompt  pressure  response
o  the  embolization  procedure  suggest  that  this  was  the
ause  of  the  hypertension.  Malignant  hypertension  can  be
eﬁned  as  extremely  high  blood  pressure  with  associated
apilledema.  The  pathogenesis  of  MH  is  poorly  understood
ut  disturbances  in  the  renal  release  of  vasoconstrictors  and
echanical  stress  on  vessels’  walls  appear  to  be  critical.  This
s  the  seventh  report  on  malignant  hypertension-associated
AH.  The  main  characteristics  of  this  one  and  of  the  previous
eports  are  described  in  Table  1.  This  possible  new  syndrome
isplays  some  striking  characteristics:  all  patients  are,  rel-
tively  young,  males,  with  4  out  of  7  were  smokers.  There
as  also  a  predominance  of  Asians.  Since  the  incidence  of
alignant  hypertension  is  not  increased  in  males,  there  may
e  some  relevance  to  this  gender  predominance.
These  reports  suggest  that  extreme  hypertension  can
ead  to  pulmonary  haemorrhage,  similar  to  pulmonary  renal
yndrome  caused  by  an  immune-mediated  mechanism.  The
echanism  of  how  high  blood  pressure  can  cause  alveolar
aemorrhage  remains  unclear,  but  humoral  factors1 might  be
nvolved  in  the  alveolar  capillaries.  The  damaged  endothe-
ium  increases  permeability  and  activates  the  coagulation
ascade,  including  platelet  activation  and  ﬁbrin  deposition.
ed  blood  cells  are  destroyed  within  vessels,2 which  may
xplain  why  up  to  one-third  of  patients  do  not  present  with
aemoptysis.  Hida  et  al.,1 argued  that  alveolar  capillaries
ight  be  injured  by  malignant  hypertension  in  the  same
ay  as  systemic  capillaries.  However,  Sato  et  al.3 and  Aithal
t  al.4 concluded  that  left  ventricular  dysfunction  resulting
rom  systemic  hypertension  can  cause  pulmonary  oedema,
eading  to  haemorrhage.  On  the  other  hand,  Dalal  et  al.5
howed  that  smoking,  platelet  dysfunction  due  to  under-
ing  uraemia  and  thrombocytopenia  may  also  predispose
o  development  of  pulmonary  haemorrhage.  Sato  et  al.3
nd  Dalal  et  al.5 suggest  that  previous  air  travel  may  havePlease  cite  this  article  in  press  as:  Duarte  JC,  et  al.  System
haemorrhage.  Rev  Port  Pneumol.  2016.  http://dx.doi.org/10.1
ontributed  to  the  development  of  DAH,  with  an  underly-
ng  mechanism  similar  to  high  altitude  pulmonary  oedema.
owever,  it  is  worth  noting  that  no  other  ﬁndings  have  sup-
orted  this  hypothesis,  and  this  may  be  just  a  non-signiﬁcant
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ssociation.  In  conclusion,  our  and  previous  reports  of  malig-
ant  hypertension  associated  DAH  suggest  that  high  blood
ressure  may  be  a  signiﬁcant  cause  of  alveolar  haemorr-
age.  Clinicians  caring  for  DAH  patients  should  be  aware  of
his  association.  We  also  propose  large-scale  studies  on  the
ssociation  between  systemic  blood  pressure  and  the  risk
f  alveolar  haemorrhage  which  could  open  the  way  to  new
reatment  of  DAH  with  BP  lowering  agent.
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